Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues - Barron's
Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues Barron's
from Top stories - Google News August 09, 2019 at 06:59PM
Shares of biotech firm Nektar Therapeutics collapsed after the company revealed in an earnings call that there had been manufacturing issues in two batches of ...
View full coverage on Google Newsfrom Top stories - Google News August 09, 2019 at 06:59PM
Comments
Post a Comment